STOCK TITAN
  1. Home
  2. Sec-filings
  3. VIVS
  4. [ARS] VivoSim Labs, INC. SEC Filing

[ARS] VivoSim Labs, INC. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - VivoSim Labs, INC.

ARS Filing - VivoSim Labs, INC.

This filing is available as a PDF document.

Filing Type: ARS

Company: VivoSim Labs, INC. (VIVS)

Acceptance Date: 2025-11-06T16:52:12.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock VIVS logo
VivoSim Labs Inc

NASDAQ:VIVS

VIVS Rankings

#6606 Ranked by Market Cap
N/A Ranked by Dividends

VIVS Latest News

Jan 6, 2026
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer
Aug 14, 2025
VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer
May 13, 2025
VivoSim’s NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference
May 7, 2025
VivoSim Presents Best-in-Class Liver Toxicology Prediction Results at Digestive Disease Week Conference
Apr 24, 2025
VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market

VIVS Latest SEC Filings

Dec 18, 2025
[8-K] VivoSim Labs, INC. Reports Material Event
Nov 19, 2025
[Form 4] VivoSim Labs, INC. Insider Trading Activity
Nov 6, 2025
[10-Q] VivoSim Labs, INC. Quarterly Earnings Report
Nov 3, 2025
[DEF 14A] VivoSim Labs, INC. Definitive Proxy Statement
Sep 25, 2025
[RW] VivoSim Labs, INC. SEC Filing

VIVS Stock Data

5.24M
2.58M
1.13%
9.02%
1.46%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SAN DIEGO